This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Intron Biotechnology, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Min Jung You: Innovator in Peptide Compounds
Introduction
Min Jung You is a prominent inventor based in Suwon, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds with potential applications in cancer treatment. Her innovative work has led to the filing of multiple patents, showcasing her expertise and dedication to advancing medical science.
Latest Patents
Min Jung You holds 2 patents related to novel peptide compounds. Her latest patents include a peptide compound, a production method therefor, and its use. These patents detail a unique peptide compound that exhibits anticancer activity, making it a promising candidate for the prevention or treatment of cancer. The methods of production and application of this peptide compound are also thoroughly described, highlighting its potential impact on cancer therapies.
Career Highlights
Min Jung You is currently associated with Intron Biotechnology, Inc., where she continues to push the boundaries of research in biotechnology. Her work has not only contributed to her personal achievements but has also advanced the company's mission to develop innovative solutions in healthcare.
Collaborations
Throughout her career, Min Jung You has collaborated with notable colleagues, including Jong Heon Shin and Ki Bong Oh. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological innovations.
Conclusion
Min Jung You is a trailblazer in the field of peptide compounds, with her work holding significant promise for cancer treatment. Her contributions to biotechnology through her patents and collaborations reflect her commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile